ClinicalTrials.Veeva

Menu

A Cost Effective and Time Saving Blood Test to Detect Six Human Bloodborne Infectious Diseases (SAFE-Blood)

University Hospital Center (CHU) logo

University Hospital Center (CHU)

Status

Unknown

Conditions

HIV
Viral Hepatitis

Study type

Observational

Funder types

Other

Identifiers

NCT04304612
RECHMPL20_0141

Details and patient eligibility

About

The consortium will develop a new in vitro diagnostic (IVD) test to screen donated blood for bloodborne infectious pathogens, saving blood banks time and costs required for analysis of mandatory pathogens. The IVD test is a multiplex immunoassay that simultaneously screens for six bloodborne infectious diseases per blood sample. In this project, a mix of diagnostic protein markers will be developed and validated to lowdown an IVD test ready for commercial scale-up and CE-IVD certification.

Enrollment

500 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Samples having been tested positive or negative for the serological markers explored in the study

Exclusion criteria

  • to refuse to participate to the study

Trial contacts and locations

1

Loading...

Central trial contact

Edouard TUAILLON, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems